EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC 3.0

Denosumab for Primary Osteoporosis and Its Impact on Sarcopenia in the Chinese Population: Insights from Clinical Evidence and RANKL Pathway Mendelian Randomization

Shaotian Li iD, Shanshan Hu, Xiaoli Zheng, Xiong Ku, Jingfeng Zou iD, Liping Wang, Guqiao Nie, Yiting Liu iD, Chunhui Tian iD, Jiajia Ran iD, Xin Yang, Mi Yan und 4 weitere

Clinical Interventions in Aging · 2025

DOI: 10.2147/cia.s547803 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Clinical Interventions in Aging, 2025. Verfasst von Shaotian Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Union Hospital TongJi Medical College HuaZhong University of Science and Technology, Wuhan, Hubei, People's Republic of China. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Denosumab, Osteoporosis, RANK Ligand. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Density Conservation AgentsDenosumabOsteoporosisRANK LigandSarcopeniaAgedFemaleHumansMaleMiddle AgedBone DensityChinaGenome-Wide Association StudyMendelian Randomization AnalysisMuscle StrengthEast Asian People

Stichwörter der Autor:innen

Mendelian randomizationRANKL genedenosumabosteoporosissarcopenia

Substanzen

Bone Density Conservation AgentsDenosumabRANK LigandTNFSF11 protein, human

Autor:innen und Institutionen

  • Union Hospital TongJi Medical College HuaZhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
  • Geriatric hospital Affiliated to Wuhan University of science and technology, Wuhan, Hubei, People's Republic of China.

ORCID-Profile: Shaotian Li, Jingfeng Zou, Yiting Liu, Chunhui Tian, Jiajia Ran

Zitieren

APA

Li, S., Hu, S., Zheng, X., Ku, X., Zou, J., Wang, L., Nie, G., Liu, Y., Tian, C., Ran, J., Yang, X., Yan, M., Yin, Y., Liu, Y., Wan, J., & Peng, W. (2025). Denosumab for Primary Osteoporosis and Its Impact on Sarcopenia in the Chinese Population: Insights from Clinical Evidence and RANKL Pathway Mendelian Randomization. Clinical Interventions in Aging. https://doi.org/10.2147/cia.s547803

Vancouver

Li S, Hu S, Zheng X, Ku X, Zou J, Wang L, et al. Denosumab for Primary Osteoporosis and Its Impact on Sarcopenia in the Chinese Population: Insights from Clinical Evidence and RANKL Pathway Mendelian Randomization. Clinical Interventions in Aging. 2025. doi:10.2147/cia.s547803

BibTeX
@article{Li2025,
  author = {Li, Shaotian and Hu, Shanshan and Zheng, Xiaoli and Ku, Xiong and Zou, Jingfeng and Wang, Liping and Nie, Guqiao and Liu, Yiting and Tian, Chunhui and Ran, Jiajia and Yang, Xin and Yan, Mi and Yin, Yilan and Liu, Yun and Wan, Jingjing and Peng, Wen},
  title = {Denosumab for Primary Osteoporosis and Its Impact on Sarcopenia in the Chinese Population: Insights from Clinical Evidence and RANKL Pathway Mendelian Randomization},
  journal = {Clinical Interventions in Aging},
  year = {2025},
  doi = {10.2147/cia.s547803}
}
Kostenlos starten →